2012-10-10 09:13:47 - Recently published research from Global Markets Direct, "Perennial Allergic Rhinitis - Pipeline Review, H2 2012", is now available at Fast Market Research

Global Markets Direct's, 'Perennial Allergic Rhinitis - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Perennial Allergic Rhinitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Perennial Allergic Rhinitis. Perennial Allergic Rhinitis - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report Details at
- www.fastmr.com/prod/468469_perennial_allergic_rhinitis_pipeline_ ..


Note*: Certain sections in the report may be

removed or altered based on the availability and relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Perennial Allergic Rhinitis.
* A review of the Perennial Allergic Rhinitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Perennial Allergic Rhinitis pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Perennial Allergic Rhinitis.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Perennial Allergic Rhinitis pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Perennial Allergic Rhinitis Overview
Therapeutics Development
An Overview of Pipeline Products for Perennial Allergic Rhinitis
Perennial Allergic Rhinitis Therapeutics under Development by Companies
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Pre-Clinical Stage Products
Comparative Analysis
Perennial Allergic Rhinitis Therapeutics - Products under Development by Companies
Companies Involved in Perennial Allergic Rhinitis Therapeutics Development
Shionogi & Co., Ltd.
GlaxoSmithKline plc
Nycomed International Management GmbH
Sun Pharmaceutical Industries Limited
GenMont Biotech Inc.
VentiRx Pharmaceuticals, Inc.
Adamis Pharmaceuticals Corporation
Perennial Allergic Rhinitis - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
ciclesonide - Drug Profile
Product Description
Mechanism of Action
R&D Progress
VTX-1463 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
S-555739 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
fluticasone furoate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Modified Allergen Extract - Drug Profile
Product Description
Mechanism of Action
R&D Progress
GMNL-32 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
SUN-1334 H - Drug Profile
Product Description
Mechanism of Action
R&D Progress
SUN-1334 H - Drug Profile
Product Description
Mechanism of Action
R&D Progress
TBS-6 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
APC-3000 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Perennial Allergic Rhinitis Therapeutics - Drug Profile Updates
Perennial Allergic Rhinitis Therapeutics - Dormant Products
Perennial Allergic Rhinitis - Product Development Milestones
Featured News & Press Releases
Nov 05, 2011: Sunovion's Investigational Ciclesonide Nasal Aerosol In HFA Propellant, Demonstrated Positive Results In Patients With Perennial Allergic Rhinitis
May 14, 1998: Rhone-Poulenc Rorer submits New Drug Application for once-daily, Non-Sedating Antihistamine
Oct 20, 1995: Approval Of Kestine(Ebastine) Received in Denmark; New Antihistamine Now Approved in three European Countries
Sep 13, 1994: Rhone-Poulenc Rorer And Fisons Sign Agreements To Market Respiratory Products In Europe
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for Perennial Allergic Rhinitis, H2 2012
Products under Development for Perennial Allergic Rhinitis - Comparative Analysis, H2 2012
Number of Products under Development by Companies, H2 2012
Comparative Analysis by Late Stage Development, H2 2012
Comparative Analysis by Mid Clinical Stage Development, H2 2012

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468469&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.